Katie Kissner

Quantitative Analyst
Full contact info

Experience

Cooley Advises on Candid Therapeutics’ $370 Million Capital Raise, Three-Way Merger

September 9, 2024

Cooley advised Candid Therapeutics, a biotechnology company dedicated to developing potentially transformative drugs to address autoimmune diseases, on its $370 million debut capital raise and three-way merger with Vignette Bio and TRC 2004.

Read more

Related contacts

Carlos Ramirez
Partner, San Diego
Edmond Lay
Associate, San Diego
Matthew D. Silverman
Special Counsel, Santa Monica
Ben Beerle
Partner, San Francisco
Leina Verrier
Associate, Santa Monica
Jayden Martinez
Associate, Colorado
Jack Whitaker
Associate, San Diego
Dillon Martinson
Special Counsel, Washington, DC
Stephanie Gentile
Partner, New York
Calvin Lee
Associate, New York
Megan Browdie
Partner, Washington, DC
Nicholas Orr
Associate, Los Angeles
Sharon Connaughton
Special Counsel, Washington, DC
Patricia Myers
Paralegal Specialist, Colorado
Linh Nguyen
Associate, San Diego
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Kate Walther
Paralegal Specialist, San Diego
John Sellers
Partner, Palo Alto
Katie Kissner
Quantitative Analyst, San Francisco
Jennifer Shanley
Special Counsel, New York
Natasha Leskovsek
Of Counsel, Washington, DC

Related Practices & Industries

DEFCON AI Announces $44 Million Seed Financing

August 20, 2024

Cooley advised DEFCON AI, an insights company that’s building a next-generation modeling, simulation and analysis tool set for the modern military environment, on its $44 million in Seed financing.

Read more

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Robert Warshaw
Associate, New York
David Fletcher
Partner, Washington, DC
Jim Fulton
Partner, New York
Charles Haley
Partner, Palo Alto
Christopher Kimball
Partner, Washington, DC
Jean Park
Partner, New York
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Ryan Montgomery
Special Counsel, Boston
Grant Schweikert
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Liza Cotter
Associate, Boston
Ryan Guo
Associate, New York
Norris Kadet
Associate, New York
Katharina Schwarz
Associate, New York
Jill Simon
Senior Paralegal, New York
Katie Kissner
Quantitative Analyst, San Francisco
Brandon Lefebvre
Quantitative Analyst, Boston

Related Practices & Industries

Abnormal Security Announces $250 Million Series D at a $5.1 Billion Valuation

August 6, 2024

Cooley advised Abnormal Security, the leader in AI-native human behavior security, on its $250 million Series D financing at a $5.1 billion valuation.

Read more

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Charles Haley
Partner, Palo Alto
Christopher Kimball
Partner, Washington, DC
Kevin King
Partner, Washington, DC
Amanda A. Main
Partner, Palo Alto
Howard Morse
Partner, Washington, DC
Matthew Schwee
Partner, Reston
John Sellers
Partner, Palo Alto
Milson Yu
Partner, Palo Alto
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Sharon Connaughton
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Julie Wicklund
Special Counsel, Palo Alto
William Beom Hong
Associate, Palo Alto
Gary Warren Hunt III
Associate, Washington, DC
Yuehui Ji
Associate, Palo Alto
Tiffany Le
Associate, Palo Alto
Daniel Y. Lee
Associate, Palo Alto
Yichen Liu
Associate, Palo Alto
Nan Yang
Associate, Palo Alto
Zi Ye
Associate, Palo Alto
Katie Kissner
Quantitative Analyst, San Francisco

Related Practices & Industries

Outpace Bio Announces $144 Million Oversubscribed Series B

August 1, 2024

Cooley advised Outpace Bio, a cell therapy company using unrivaled artificial intelligence-powered protein design to program immune cells for improved function inside patients battling solid tumors, on its $144 million oversubscribed Series B financing.

Read more

Related contacts

Colleen Badgley
Partner, Seattle
Sonya Erickson
Partner and Business Department Chair, Seattle
Christopher Kimball
Partner, Washington, DC
Mika Reiner Mayer
Partner, Palo Alto
John Sellers
Partner, Palo Alto
Timothy Shapiro
Partner, Palo Alto
Dillon Martinson
Special Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Lucy Bauer
Associate, Seattle
Karen Gustavson
Associate, Seattle
Millie Heuer
Associate, Seattle
Brian Woodard
Paralegal Specialist, Seattle
Katie Kissner
Quantitative Analyst, San Francisco

Related Practices & Industries

Nerio Therapeutics Sells to Boehringer Ingelheim for up to $1.3 Billion

July 29, 2024

Cooley advised Nerio Therapeutics, a drug discovery and development company focused on phosphatases, a notoriously difficult class of potentially high-value therapeutic protein targets, on its sale to Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, for up to $1.3 billion.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Charity Williams
Partner, San Diego
Rajdeep Roger Bains
Associate, San Diego
Ken Rollins
Partner in Charge – San Diego, San Diego
Alessandra Murata
Partner, Palo Alto
Tony P. Guan
Associate, Santa Monica
Lei Shen
Partner, Chicago
Allison Kutner
Associate, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Jeffrey J. Tolin
Partner, New York
Ross Eberly
Partner, Santa Monica
Dylan Kornbluth
Associate, San Diego
Joanna Zhang
Associate, San Diego
Allie Pilmer
Associate, San Diego
Howard Morse
Partner, Washington, DC
Ajay Athavale
Associate, San Francisco
Sharon Connaughton
Special Counsel, Washington, DC
Katie Kissner
Quantitative Analyst, San Francisco

Related Practices & Industries

Education

Santa Clara University
MS, 2022, Finance and Analytics

University of California, San Diego
BS, 2019, Mathematics and Economics, Business minor